Massive chart review aims to unravel cachexia in lung and GI cancers
NCT ID NCT03606317
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the medical records of 20,000 patients with lung or gastrointestinal cancer who also have cachexia (severe weight loss and muscle wasting). The goal is to learn how cachexia is currently managed and what factors affect patient outcomes. No treatments or tests are given; researchers simply analyze existing data from two hospitals.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how cachexia progresses and how it is currently managed, pointing toward improved care guidelines.
- What could go wrong
- This is a retrospective chart review, not a treatment trial. It cannot prove what works best, only describe past practices. Results may not apply to other hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection